Eyal Robenshtok

• •  
  • Eyal Robenshtok's presentations
    • Response to Therapy Assessment in Intermediate-Risk Differentiated Thyroid Cancer Patients – Is rhTSH Stimulation Required?
    • Detecting Recurrence Following Lobectomy for Differentiated Thyroid Cancer: The Role of Thyroglobulin and Anti-thyroglobulin Antibodies

  Dr. Robenshtok is an endocrinologist and thyroid cancer specialist at the Rabin Medical Center, and the head of the thyroid cancer clinic at the Davidoff Cancer Center in Israel.  He graduated from the Hadassah Medical School in Jerusalem with his MD degree, and completed his training and endocrinology fellowship at the Rabin Medical Center. In 2012 he completed the thyroid cancer fellowship at Memorial Sloan-Kettering Cancer Center, New York. Dr. Robenshtok’s research focuses on individualized, risk stratified management of thyroid cancer, and his studies were published in leading scientific journals, including Thyroid and JCEM and more. He is an active member of the ATA, ETA, IES and the EORTC Endocrine Task Force. In 2019 Dr. Robenshtok was awarded the Lindner Prize of the Israel Endocrine Society, in recognition for his scientific achievements and contribution in the field of thyroid cancer.